Guild Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Guild Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,800	Closed	-$1.06M	–	80
2021 Q1	$1.06M	Sell	7,800 -2,370	-23%	-$355K	1.13%	31
2020 Q4	$1.43M	Buy	10,170 +1,274	+14%	+$163K	1.58%	30
2020 Q3	$991K	Sell	8,896 -50	-0.6%	-$5.61K	1.36%	30
2020 Q2	$1M	Sell	8,946 -1,860	-17%	-$183K	1.42%	29
2020 Q1	$837K	Buy	10,806 +4,026	+59%	+$357K	1.82%	23
2019 Q4	$645K	Buy	+6,780	New	+$586K	0.83%	35
2019 Q2	–	Sell	-16,400	Closed	-$1.49M	–	51
2019 Q1	$1.49M	Buy	+16,400	New	+$1.4M	1.94%	20
2017 Q4	–	Sell	-11,610	Closed	-$1M	–	49
2017 Q3	$1M	Buy	+11,610	New	+$931K	1.06%	19

Other funds holding XBI

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Guild Investment Management's XBI Position: Q2 2021 in Review

Guild Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 7,800 shares — an estimated $1.06M sold.

Guild Investment Management first reported a position in XBI in Q3 2017 and held it in 8 quarters. The position peaked at $1.49M in Q1 2019. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

Guild Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
Guild Investment Management sold 7,800 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $1.06M.
Guild Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and held it in 8 quarters.
Guild Investment Management's State Street SPDR S&P Biotech ETF position peaked at $1.49M in Q1 2019.
663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on Guild Investment Management's 13F filing for Q2 2021, filed 28 Jul 2021.